<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="AMP-activated protein kinase,Serine/threonine-specific protein kinases,Serine/threonine-specific protein kinases,2001,2002,3-phosphoglycerate,ACC,ADP,AKT,ALAS,AMP" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>AMP-activated protein kinase - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">AMP-activated protein kinase</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <p><b>5'AMP-activated protein kinase</b> or <b>AMPK</b> consists of three proteins (<a href="../../../s/u/b/Subunits.html" title="Subunits">subunits</a>) that together make a functional <a href="../../../e/n/z/Enzyme.html" title="Enzyme">enzyme</a>, conserved from yeast to humans, that plays a role in cellular energy homeostasis. It is expressed in a number of tissues, including the <a href="../../../l/i/v/Liver.html" title="Liver">liver</a>, <a href="../../../b/r/a/Brain.html" title="Brain">brain</a>, and <a href="../../../s/k/e/Skeletal_muscle.html" title="Skeletal muscle">skeletal muscle</a>. The net effect of AMPK activation is stimulation of <a href="../../../h/e/p/Hepatic.html" title="Hepatic">hepatic</a> fatty acid oxidation and <a href="../../../k/e/t/Ketogenesis.html" title="Ketogenesis">ketogenesis</a>, inhibition of <a href="../../../c/h/o/Cholesterol.html" title="Cholesterol">cholesterol</a> synthesis, <a href="../../../l/i/p/Lipogenesis.html" title="Lipogenesis">lipogenesis</a>, and <a href="../../../t/r/i/Triglyceride.html" title="Triglyceride">triglyceride</a> synthesis, inhibition of adipocyte <a href="../../../l/i/p/Lipolysis.html" title="Lipolysis">lipolysis</a> and lipogenesis, stimulation of skeletal muscle fatty acid oxidation and muscle glucose uptake, and modulation of insulin secretion by <a href="../../../p/a/n/Pancreatic.html" title="Pancreatic">pancreatic</a> <a href="../../../b/e/t/Beta-cells.html" title="Beta-cells">beta-cells</a> (4).</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Structure"><span class="tocnumber">1</span> <span class="toctext">Structure</span></a></li>
<li class="toclevel-1"><a href="#Function"><span class="tocnumber">2</span> <span class="toctext">Function</span></a></li>
<li class="toclevel-1"><a href="#AMPK_Activation"><span class="tocnumber">3</span> <span class="toctext">AMPK Activation</span></a></li>
<li class="toclevel-1"><a href="#AMPK_and_Exercise.2FTraining"><span class="tocnumber">4</span> <span class="toctext">AMPK and Exercise/Training</span></a></li>
<li class="toclevel-1"><a href="#AMPKK_and_Exercise.2FTraining"><span class="tocnumber">5</span> <span class="toctext">AMPKK and Exercise/Training</span></a></li>
<li class="toclevel-1"><a href="#AMPK_and_Adipocytokine_Relations"><span class="tocnumber">6</span> <span class="toctext">AMPK and Adipocytokine Relations</span></a></li>
<li class="toclevel-1"><a href="#AMPK_and_Lipid_Metabolism"><span class="tocnumber">7</span> <span class="toctext">AMPK and Lipid Metabolism</span></a></li>
<li class="toclevel-1"><a href="#AMPK_and_Glucose_Transport"><span class="tocnumber">8</span> <span class="toctext">AMPK and Glucose Transport</span></a></li>
<li class="toclevel-1"><a href="#AMPK_and_Mitochondria"><span class="tocnumber">9</span> <span class="toctext">AMPK and Mitochondria</span></a></li>
<li class="toclevel-1"><a href="#Thyroid_Hormone_and_AMPK"><span class="tocnumber">10</span> <span class="toctext">Thyroid Hormone and AMPK</span></a></li>
<li class="toclevel-1"><a href="#Controversy"><span class="tocnumber">11</span> <span class="toctext">Controversy</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">12</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">13</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Structure" id="Structure"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: Structure">edit</a>]</span> <span class="mw-headline">Structure</span></h2>
<p>The heterotrimeric protein AMPK is formed by α, β, and γ subunits. Each of these three subunits takes on a specific role for both the stability and activity of AMPK (11). Specifically, the γ subunit includes four particular Cystathione <a href="../../../b/e/t/Beta.html" title="Beta">Beta</a> <a href="../../../s/y/n/Synthase.html" title="Synthase">Synthase</a> (CBS) domains giving AMPK its ability to sensitively detect shifts in the AMP:<a href="../../../a/t/p/ATP_40ef.html" title="ATP">ATP</a> ratio. The four CBS domains create two binding sites for AMP commonly referred to as Bateman domains. Binding of one <a href="../../../a/m/p/AMP_9c37.html" title="AMP">AMP</a> to a Bateman domain cooperatively increases the binding <a href="../../../a/f/f/Affinity.html" title="Affinity">affinity</a> of the second AMP to the other Bateman domain (49). As AMP binds both Bateman domains the γ subunit undergoes a conformational change which exposes the <a href="../../../c/a/t/Catalytic.html" title="Catalytic">catalytic</a> domain found on the α subunit. It is in this catalytic domain where AMPK becomes activated when <a href="../../../p/h/o/Phosphorylation.html" title="Phosphorylation">phosphorylation</a> takes place at <a href="../../../t/h/r/Threonine.html" title="Threonine">threonine</a>-172 by an <a href="../../../u/p/s/Upstream.html" title="Upstream">upstream</a> AMPK <a href="../../../k/i/n/Kinase.html" title="Kinase">kinase</a> (AMPKK) (19). The α, β, and γ subunits can also be found in different isoforms: the γ subunit can exist as either the γ1, γ2 or γ3 <a href="../../../i/s/o/Isoform.html" title="Isoform">isoform</a>; the β subunit can exist as either the β1 or β2 isoform; and the α subunit can exist as either the α1 or α2 isoform. Although the most common isoforms expressed in most cells are the α1, β1, and γ1 isoforms, it has been demonstrated that the α2, β2, γ2, and γ3 isoforms are also expressed in <a href="../../../c/a/r/Cardiac.html" title="Cardiac">cardiac</a> and [skeletal muscle (11, 12, 13).</p>
<p><a name="Function" id="Function"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: Function">edit</a>]</span> <span class="mw-headline">Function</span></h2>
<p>AMPK acts as a <a href="../../../m/e/t/Metabolic.html" title="Metabolic">metabolic</a> master switch regulating several <a href="../../../i/n/t/Intracellular.html" title="Intracellular">intracellular</a> systems including the cellular uptake of <a href="../../../g/l/u/Glucose.html" title="Glucose">glucose</a>, the <a href="../../../%CE%B2/-/o/%CE%92-oxidation.html" title="Β-oxidation">β-oxidation</a> of <a href="../../../f/a/t/Fatty_acids.html" title="Fatty acids">fatty acids</a> and the <a href="../../../b/i/o/Biogenesis.html" title="Biogenesis">biogenesis</a> of glucose transporter 4 (<a href="../../../g/l/u/GLUT4_ae54.html" title="GLUT4">GLUT4</a>) and <a href="../../../m/i/t/Mitochondria.html" title="Mitochondria">mitochondria</a> (1, 2, 4, 5, 36). The energy-sensing capability of AMPK can be attributed to its ability to detect and react to fluctuations in the AMP:ATP ratio that take place during <a href="../../../r/e/s/Rest.html" title="Rest">rest</a> and <a href="../../../e/x/e/Exercise.html" title="Exercise">exercise</a> (muscle stimulation). During <a href="../../../m/u/s/Muscle.html" title="Muscle">muscle</a> stimulation, AMP increases while ATP decreases, which changes AMPK into a good substrate for activation via an upstream kinase complex, AMPKK. AMPKK is a complex of three proteins, STE-related adaptor (STRAD), mouse protein 25 (MO25), and LKB1 (a <a href="../../../s/e/r/Serine.html" title="Serine">serine</a>/threonine kinase). During a bout of exercise, AMPK activity increases while the muscle cell experiences metabolic <a href="../../../s/t/r/Stress_%28medicine%29.html" title="Stress (medicine)">stress</a> brought about by an extreme cellular demand for ATP. Upon activation, AMPK increases celluar energy levels by inhibiting <a href="../../../a/n/a/Anabolic.html" title="Anabolic">anabolic</a> energy consuming pathways (fatty acid <a href="../../../s/y/n/Synthesis.html" title="Synthesis">synthesis</a>, <a href="../../../p/r/o/Protein.html" title="Protein">protein</a> synthesis, etc.) and stimulating energy producing, <a href="../../../c/a/t/Catabolic.html" title="Catabolic">catabolic</a> pathways (fatty acid oxidation, glucose transport, etc.).</p>
<p>Recent <a href="../../../r/e/s/Research.html" title="Research">research</a> on <a href="../../../m/o/u/Mouse.html" title="Mouse">mice</a> at <a href="../../../h/a/r/Harvard_University_9346.html" title="Harvard University">Harvard University</a> has shown that when the activity of AMPK was inhibited, the mice ate less and lost weight, but these data are controversial. When AMPK levels were artificially raised the mice ate more and gained weight. Research in Britain has shown that the appetite-stimulating hormone <a href="../../../g/h/r/Ghrelin.html" title="Ghrelin">ghrelin</a> also affects AMPK levels.</p>
<p>A <a href="../../../2/0/0/2001.html" title="2001">2001</a> study (Zhou G <i>et al</i>) has indicated that the <a href="../../../a/n/t/Antidiabetic_drug.html" title="Antidiabetic drug">antidiabetic drug</a> <a href="../../../m/e/t/Metformin.html" title="Metformin">metformin</a> (Glucophage®) acts by stimulating AMPK, leading to improved <a href="../../../i/n/s/Insulin_resistance.html" title="Insulin resistance">insulin resistance</a> in the <a href="../../../l/i/v/Liver.html" title="Liver">liver</a>.</p>
<p><a name="AMPK_Activation" id="AMPK_Activation"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: AMPK Activation">edit</a>]</span> <span class="mw-headline">AMPK Activation</span></h2>
<p>Triggering the activation of AMPK can be carried out provided that two conditions are met. First, the γ subunit of AMPK must undergo a conformational change so as to expose the <a href="../../../a/c/t/Active_site.html" title="Active site">active site</a> (Thr-172) on the α subunit. The conformational change of the γ subunit of AMPK can be accomplished under increased concentrations of AMP. Increased concentrations of AMP will give rise to the conformational change on the γ subunit of AMPK as two AMP bind the two Bateman domains located on that subunit. It is this conformational change brought about by increased concentrations of AMP that exposes the active site (Thr-172) on the α subunit. This critical role of AMP is further substantiated in experiments that demonstrate AMPK activation via an AMP analogue 5-amino-4-imidazolecarboxamide ribotide (ZMP) which is derived from the familiar 5-amino-4-imidazolecarboxamide riboside (AICAR) (14, 15, 16, 17). The second condition that must be met is the phosphorylation and consequent activation of AMPK on its activating loop at Thr-172 of the α subunit brought about by an upstream kinase (AMPKK) (19, 20). The complex formed between LKB1 (STK 11), mouse protein 25 (MO25), and the pseudokinase STE-related adaptor protein (STRAD) has of late been identified as the major upstream kinase responsible for phosphorylation of AMPK on its activating loop at Thr-172 (21, 22, 23). Although AMPK must be phosphorylated by the LKB1/MO25/STRAD complex, it can also be regulated by allosteric <a href="../../../m/o/d/Modulator.html" title="Modulator">modulators</a> which directly increase general AMPK activity and modify AMPK to make it a better <a href="../../../s/u/b/Substrate.html" title="Substrate">substrate</a> for AMPKK and a worse substrate for <a href="../../../p/h/o/Phosphatase.html" title="Phosphatase">phosphatases</a> (19, 20, 24). It has recently been found that <a href="../../../3/-/p/3-phosphoglycerate.html" title="3-phosphoglycerate">3-phosphoglycerate</a> (<a href="../../../g/l/y/Glycolysis.html" title="Glycolysis">glycolysis</a> <a href="../../../i/n/t/Intermediate.html" title="Intermediate">intermediate</a>) acts to further pronounce AMPK activation via AMPKK.</p>
<p>Muscle <a href="../../../c/o/n/Contraction.html" title="Contraction">contraction</a> is the main method carried out by the body that can provide the conditions mentioned above needed for AMPK activation (25). As muscles contract, ATP is hydrolyzed, forming <a href="../../../a/d/p/ADP_a771.html" title="ADP">ADP</a>. ADP then helps to replenish cellular ATP by donating a <a href="../../../p/h/o/Phosphate.html" title="Phosphate">phosphate</a> group to another ADP, forming an ATP and an AMP. As more AMP is produced during muscle contraction, the AMP:ATP ratio dramatically increases, leading to the <a href="../../../a/l/l/Allosteric.html" title="Allosteric">allosteric</a> activation of AMPK (10, 26, 27). This fact is further authenticated with studies, such as those sited above, that used electrical stimuli as a means to contract muscle to facilitate AMPK activation (1, 6, 18, 28, 29).</p>
<p>For over a decade it has been known that <a href="../../../c/a/l/Calmodulin.html" title="Calmodulin">calmodulin</a>-dependent protein kinase kinase-beta (CaMKKbeta) can phosphorylate and thereby activate AMPK, but it was not the main AMPKK in <a href="../../../l/i/v/Liver.html" title="Liver">liver</a> (26). Richter et al (27) found that CaMKK inhibitors strongly inhibited AMPK phosphorylation in <a href="../../../m/o/u/Mouse.html" title="Mouse">mouse</a> <a href="../../../s/o/l/Soleus.html" title="Soleus">soleus</a> and EDL muscles after 2 minutes of <a href="../../../c/o/n/Contraction.html" title="Contraction">contraction</a>, but much less as time of contraction increased. CaMKK inhibitors had no effect on 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) phosphorylation and activation of AMPK (27). AICAR is taken into the <a href="../../../c/e/l/Cell_%28biology%29.html" title="Cell (biology)">cell</a> and converted to ZMP, an AMP <a href="../../../a/n/a/Analog_%28chemistry%29.html" title="Analog (chemistry)">analog</a> that has been shown to activate AMPK (28). Recent LKB1 knockout studies have shown that without LKB1, electrical and AICAR stimulation of <a href="../../../m/u/s/Muscle.html" title="Muscle">muscle</a> results in very little phosphorylation of AMPK and of <a href="../../../a/c/c/ACC_c4fd.html" title="ACC">ACC</a>, providing evidence that LKB1-STRAD-MO25 is the major AMPKK in muscle (29).</p>
<p><br /></p>
<p><a name="AMPK_and_Exercise.2FTraining" id="AMPK_and_Exercise.2FTraining"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: AMPK and Exercise/Training">edit</a>]</span> <span class="mw-headline">AMPK and Exercise/Training</span></h2>
<p>Many <a href="../../../b/i/o/Biochemical.html" title="Biochemical">biochemical</a> adaptations of skeletal muscle that take place during a single bout of <a href="../../../e/x/e/Exercise.html" title="Exercise">exercise</a> or an extended duration of <a href="../../../t/r/a/Training.html" title="Training">training</a>, such as increased mitochondrial biogenesis and capacity (31, 32), increased muscle <a href="../../../g/l/y/Glycogen.html" title="Glycogen">glycogen</a> (37), and an increase in <a href="../../../e/n/z/Enzyme.html" title="Enzyme">enzymes</a> which specialize in glucose uptake in cells such as GLUT4 and <a href="../../../h/e/x/Hexokinase.html" title="Hexokinase">Hexokinase</a> II (33, 35, 37) are thought to be mediated in part by AMPK when it is activated (2, 34). Additionally, recent discoveries can conceivably suggest a direct AMPK role in increasing blood supply to exercised/trained muscle cells by stimulating and stabilizing both <a href="../../../v/a/s/Vasculogenesis.html" title="Vasculogenesis">vasculogenesis</a> and <a href="../../../a/n/g/Angiogenesis.html" title="Angiogenesis">angiogenesis</a> (30). Taken together, these <a href="../../../a/d/a/Adaptation.html" title="Adaptation">adaptations</a> most likely transpire as a result of both temporary and maintained increases in AMPK activity brought about by increases in the AMP:ATP ratio during single bouts of exercise and long-term training.</p>
<p>During a single <a href="../../../a/c/u/Acute.html" title="Acute">acute</a> exercise bout, AMPK takes on immediate roles to allow the contracting muscle cells adapt to the energy challenges taking place by increasing Hexokinase II expression (37), GLUT4 translocation to the <a href="../../../p/l/a/Plasma_membrane.html" title="Plasma membrane">plasma membrane</a> (28, 40, 41, 42) for glucose uptake, and by stimulating glycolysis (50). If exercise bouts continue through a long-term <a href="../../../t/r/a/Training.html" title="Training">training</a> regimen, AMPK and other signals will facilitate contracting muscle adaptations by escorting muscle cell activity to a metabolic transition resulting in an <a href="../../../o/x/i/Oxidative.html" title="Oxidative">oxidative</a> dependent approach to <a href="../../../e/n/e/Energy.html" title="Energy">energy</a> <a href="../../../m/e/t/Metabolism.html" title="Metabolism">metabolism</a> as opposed to a <a href="../../../g/l/y/Glycolytic.html" title="Glycolytic">glycolytic</a> approach. AMPK accomplishes this transition to the oxidative mode of metabolism by upregulating and activating oxidative enzymes such as GLUT4, Hexokinase II, PPARalpha, PGC-1, UCP-3, <a href="../../../c/y/t/Cytochrome_C_dbc8.html" title="Cytochrome C">Cytochrome C</a> and TFAM, just to name a few (2, 35, 37, 38, 39, 43).</p>
<p><br /></p>
<p><a name="AMPKK_and_Exercise.2FTraining" id="AMPKK_and_Exercise.2FTraining"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: AMPKK and Exercise/Training">edit</a>]</span> <span class="mw-headline">AMPKK and Exercise/Training</span></h2>
<p>AMPK activity increases with exercise and the LKB1/MO25/STRAD <a href="../../../c/o/m/Complex.html" title="Complex">complex</a> is considered to be the major <a href="../../../u/p/s/Upstream.html" title="Upstream">upstream</a> AMPKK of the 5’-AMP-activated protein kinase phosphorylating the α subunit of AMPK at Thr-172 (19, 20, 21, 22). This fact is puzzling considering that although AMPKK <a href="../../../p/r/o/Protein.html" title="Protein">protein</a> abundance has been shown to increase in skeletal <a href="../../../t/i/s/Tissue.html" title="Tissue">tissue</a> with <a href="../../../e/n/d/Endurance.html" title="Endurance">endurance</a> training, its level of activity has been shown to decrease with endurance training in both trained and untrained tissue (18, 29, 45, 46). Currently, the activity of AMPKK immediately following a 2-hr bout of exercise of an endurance trained rat is unclear. It is possible that there exists a direct link between the observed decrease in AMPKK activity in endurance trained skeletal muscle and the apparent decrease in the AMPK response to exercise with endurance training.</p>
<p><br /></p>
<p><a name="AMPK_and_Adipocytokine_Relations" id="AMPK_and_Adipocytokine_Relations"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: AMPK and Adipocytokine Relations">edit</a>]</span> <span class="mw-headline">AMPK and Adipocytokine Relations</span></h2>
<p><a href="../../../a/d/i/Adipokine.html" title="Adipokine">Adipokines</a>, also known as <a href="../../../a/d/i/Adipocytokine.html" title="Adipocytokine">adipocytokines</a>, are secreted by <a href="../../../a/d/i/Adipose_tissue.html" title="Adipose tissue">adipose tissue</a> to take on several different but important physiological roles in the body including the regulation of <a href="../../../a/p/p/Appetite.html" title="Appetite">appetite</a>, metabolism, fatty acid catabolism, <a href="../../../c/o/a/Coagulation.html" title="Coagulation">coagulation</a> and systemic <a href="../../../i/n/f/Inflammation.html" title="Inflammation">inflammation</a>, for example. Collectively, the adipokines are in essence <a href="../../../c/y/t/Cytokine.html" title="Cytokine">cytokines</a> (cell-to-cell signaling proteins) which, when secreted, act on other cells, usually resulting in a <a href="../../../b/i/o/Biochemical.html" title="Biochemical">biochemical</a> and metabolic response. Two particular adipokines, <a href="../../../a/d/i/Adiponectin.html" title="Adiponectin">adiponectin</a> and <a href="../../../l/e/p/Leptin.html" title="Leptin">leptin</a>, have even been demonstrated to regulate AMPK.</p>
<p>It has been known for some time now that among many of the metabolic roles of leptin, one of its main functions in skeletal muscle is the <a href="../../../u/p/r/Upregulation.html" title="Upregulation">upregulation</a> of fatty acid oxidation. Recently, a study revealed that leptin is able to do this by way of the AMPK signaling pathway (44). A similar study showed that much like leptin, adiponectin also stimulates the oxidation of fatty acids via the AMPK pathway, and that it also stimulates the uptake of glucose in skeletal muscle (45). As of yet, the metabolic roles of leptin and adiponectin pertaining to biochemical adaptations to long-term <a href="../../../e/n/d/Endurance.html" title="Endurance">endurance</a> training remain unclear. Certainly future studies will involve an investigation of leptin and adiponectin activities and their respective relationships with the AMPK signaling pathway immediately following a high-intensity endurance training <a href="../../../p/r/o/Protocol_%28natural_sciences%29.html" title="Protocol (natural sciences)">protocol</a>.</p>
<p><br /></p>
<p><a name="AMPK_and_Lipid_Metabolism" id="AMPK_and_Lipid_Metabolism"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: AMPK and Lipid Metabolism">edit</a>]</span> <span class="mw-headline">AMPK and Lipid Metabolism</span></h2>
<p>One of the effects of <a href="../../../e/x/e/Exercise.html" title="Exercise">exercise</a> is an increase in <a href="../../../f/a/t/Fatty_acid_metabolism.html" title="Fatty acid metabolism">fatty acid metabolism</a>, which provides more <a href="../../../e/n/e/Energy.html" title="Energy">energy</a> for the cell. One of the key pathways in AMPK’s regulation of <a href="../../../f/a/t/Fatty_acid_oxidation.html" title="Fatty acid oxidation">fatty acid oxidation</a> is the phosphorylation and inactivation of <a href="../../../a/c/e/Acetyl-CoA_carboxylase_f16a.html" title="Acetyl-CoA carboxylase">acetyl-CoA carboxylase</a> (30). Acetyl-CoA carboxylase (ACC) converts acetyl-CoA to <a href="../../../m/a/l/Malonyl-CoA_4e88.html" title="Malonyl-CoA">malonyl-CoA</a>, an <a href="../../../i/n/h/Inhibitor.html" title="Inhibitor">inhibitor</a> of carnitine parmitoyltransferase 1 (CPT-1). CPT-1 transports <a href="../../../f/a/t/Fatty_acids.html" title="Fatty acids">fatty acids</a> into the <a href="../../../m/i/t/Mitochondria.html" title="Mitochondria">mitochondria</a> for <a href="../../../o/x/i/Oxidation.html" title="Oxidation">oxidation</a>. Inactivation of ACC, therefore, results in increased fatty acid transport and subsequent oxidation. It is also thought that the decrease in malonyl-CoA occurs as a result of <a href="../../../m/a/l/Malonyl-CoA_decarboxylase_6620.html" title="Malonyl-CoA decarboxylase">malonyl-CoA decarboxylase</a> (MCD), which may be regulated by AMPK (31). MCD is an <a href="../../../a/n/t/Antagonist.html" title="Antagonist">antagonist</a> to ACC, decarboxylating malonyl-CoA to acetyl-CoA, resulting in decreased malonyl-CoA and increased CPT-1 and fatty acid oxidation. AMPK also plays an important role in <a href="../../../l/i/p/Lipid_metabolism.html" title="Lipid metabolism">lipid metabolism</a> in the <a href="../../../l/i/v/Liver.html" title="Liver">liver</a>. It has long been known that <a href="../../../h/e/p/Hepatic.html" title="Hepatic">hepatic</a> ACC has been regulated in the liver by <a href="../../../p/h/o/Phosphorylation.html" title="Phosphorylation">phosphorylation</a> (32). AMPK also phosphorylates and inactivates 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), a key enzyme in cholesterol synthesis (28). HMGR converts 3-hydroxy-3-methylglutaryl-CoA, which is made from acetyl-CoA, into <a href="../../../m/e/v/Mevalonic_acid.html" title="Mevalonic acid">mevalonic acid</a>, which then travels down several more metabolic steps to become <a href="../../../c/h/o/Cholesterol.html" title="Cholesterol">cholesterol</a>. AMPK, therefore, helps regulate fatty acid oxidation and cholesterol synthesis.</p>
<p><br /></p>
<p><a name="AMPK_and_Glucose_Transport" id="AMPK_and_Glucose_Transport"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: AMPK and Glucose Transport">edit</a>]</span> <span class="mw-headline">AMPK and Glucose Transport</span></h2>
<p><a href="../../../i/n/s/Insulin.html" title="Insulin">Insulin</a> is a <a href="../../../h/o/r/Hormone.html" title="Hormone">hormone</a> which helps regulated <a href="../../../g/l/u/Glucose.html" title="Glucose">glucose</a> levels in the body. When blood glucose is high, insulin is released from the <a href="../../../i/s/l/Islets_of_Langerhans_f5d9.html" title="Islets of Langerhans">Islets of Langerhans</a>. Insulin, among other things, will then facilitate the uptake of glucose into cells via increased expression and <a href="../../../t/r/a/Translocation.html" title="Translocation">translocation</a> of glucose transporter <a href="../../../g/l/u/GLUT-4_6fed.html" title="GLUT-4">GLUT-4</a> (34). Under conditions of exercise, however, <a href="../../../b/l/o/Blood_sugar.html" title="Blood sugar">blood sugar</a> levels are not necessarily high, and insulin is not necessarily activated, yet muscles are still able to bring in glucose. AMPK seems to be responsible in part for this <a href="../../../e/x/e/Exercise.html" title="Exercise">exercise</a>-induced glucose uptake. Goodyear et al. (33) observed that with exercise, the concentration of GLUT-4 was increased in the <a href="../../../p/l/a/Plasma_membrane.html" title="Plasma membrane">plasma membrane</a>, but decreased in the <a href="../../../m/i/c/Microsomal.html" title="Microsomal">microsomal</a> membranes, suggesting that exercise facilitates the translocation of vesicular GLUT-4 to the <a href="../../../p/l/a/Plasma_membrane.html" title="Plasma membrane">plasma membrane</a>. While acute exercise increases GLUT-4 translocation, endurance training will increase the total amount of GLUT-4 protein available (35). It has been shown that both electrical contraction and AICAR treatment increase AMPK activation, glucose uptake, and GLUT-4 translocation in perfused rat <a href="../../../h/i/n/Hindlimb.html" title="Hindlimb">hindlimb</a> muscle, linking exercise-induced glucose uptake to AMPK (36, 37, 38). Chronic AICAR injections, simulating some of the effects of <a href="../../../e/n/d/Endurance_training.html" title="Endurance training">endurance training</a>, also increase the total amount of GLUT-4 <a href="../../../p/r/o/Protein.html" title="Protein">protein</a> in the <a href="../../../m/u/s/Muscle_cell.html" title="Muscle cell">muscle cell</a> (39).</p>
<p>Two proteins are essential for the regulation of GLUT-4 expression at a transcriptional level – myocyte enhancer factor 2 (MEF2) and GLUT-4 enhancer factor (GEF). Mutations in the <a href="../../../d/n/a/DNA_396c.html" title="DNA">DNA</a> binding regions for either of these proteins results in <a href="../../../a/b/l/Ablation.html" title="Ablation">ablation</a> of <a href="../../../t/r/a/Transgene.html" title="Transgene">transgene</a> GLUT-4 expression (40, 41). These results prompted a study in 2005 which showed that AMPK directly phosphorylates GEF, but it doesn’t seem to directly activate MEF2 (42). AICAR treatment has been shown, however, to increase transport of both proteins into the <a href="../../../n/u/c/Nucleus.html" title="Nucleus">nucleus</a>, as well as increase the binding of both to the GLUT-4 [[<a href="../../../p/r/o/Promoter.html" title="Promoter">promoter</a> region]] (42).</p>
<p>There is another protein involved in <a href="../../../c/a/r/Carbohydrate_metabolism.html" title="Carbohydrate metabolism">carbohydrate metabolism</a> that is worthy of mention along with GLUT-4. The enzyme <a href="../../../h/e/x/Hexokinase.html" title="Hexokinase">hexokinase</a> phosphorylates a six-carbon sugar, most notably <a href="../../../g/l/u/Glucose.html" title="Glucose">glucose</a>, which is the first step in <a href="../../../g/l/y/Glycolysis.html" title="Glycolysis">glycolysis</a>. When glucose is transported into the cell it is phosphorylated by hexokinase. This phosphorylation keeps glucose from leaving the <a href="../../../c/e/l/Cell_%28biology%29.html" title="Cell (biology)">cell</a>, and by changing the structure of glucose through phosphorylation, it decreases the concentration of glucose molecules, allowing a gradient for more glucose to be transported into the cell. Hexokinase II <a href="../../../t/r/a/Transcription.html" title="Transcription">transcription</a> is increased in both red and white <a href="../../../s/k/e/Skeletal_muscle.html" title="Skeletal muscle">skeletal muscle</a> upon treatment with AICAR (43). With chronic injections of AICAR, total protein content of hexokinase II increases in <a href="../../../r/a/t/Rat.html" title="Rat">rat</a> skeletal muscle (44).</p>
<p><br /></p>
<p><a name="AMPK_and_Mitochondria" id="AMPK_and_Mitochondria"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: AMPK and Mitochondria">edit</a>]</span> <span class="mw-headline">AMPK and Mitochondria</span></h2>
<p><a href="../../../m/i/t/Mitochondria.html" title="Mitochondria">Mitochondria</a> are often called the powerhouse of the <a href="../../../c/e/l/Cell_%28biology%29.html" title="Cell (biology)">cell</a>. After <a href="../../../p/y/r/Pyruvate.html" title="Pyruvate">pyruvate</a> is formed from <a href="../../../g/l/u/Glucose.html" title="Glucose">glucose</a> during <a href="../../../g/l/y/Glycolysis.html" title="Glycolysis">glycolysis</a> in the <a href="../../../c/y/t/Cytoplasm.html" title="Cytoplasm">cytoplasm</a>, it is transported into the mitochondria, where it is oxidized to <a href="../../../a/c/e/Acetyl-CoA_5db0.html" title="Acetyl-CoA">acetyl-CoA</a> and enters the <a href="../../../c/i/t/Citric_acid_cycle.html" title="Citric acid cycle">citric acid cycle</a>. <a href="../../../o/x/i/Oxidative_phosphorylation.html" title="Oxidative phosphorylation">Oxidative phosphorylation</a> is the process by which <a href="../../../n/a/d/NADH_8215.html" title="NADH">NADH</a> and <a href="../../../f/a/d/FADH2_df4e.html" title="FADH2">FADH2</a> are oxidized and <a href="../../../o/x/y/Oxygen.html" title="Oxygen">oxygen</a> is reduced. This process creates a <a href="../../../p/r/o/Proton.html" title="Proton">proton</a> gradient which is used to drive <a href="../../../a/t/p/ATP_synthase_b997.html" title="ATP synthase">ATP synthase</a> and produce <a href="../../../a/t/p/ATP_40ef.html" title="ATP">ATP</a>. This process creates energy for cellular properties, and since ATP is indispensable in the contraction process, so then, are mitochondria.</p>
<p>Mitochondrial enzymes, such as <a href="../../../c/y/t/Cytochrome_c.html" title="Cytochrome c">cytochrome c</a>, <a href="../../../s/u/c/Succinate_dehydrogenase.html" title="Succinate dehydrogenase">succinate dehydrogenase</a>, <a href="../../../m/a/l/Malate_dehydrogenase.html" title="Malate dehydrogenase">malate dehydrogenase</a>, α-ketoglutarate dehydrogenase, and <a href="../../../c/i/t/Citrate_synthase.html" title="Citrate synthase">citrate synthase</a>, increase in expression and activity in response to exercise (45). AICAR stimulation of AMPK increases cytochrome c and δ-aminolevulinate synthase (<a href="../../../a/l/a/ALAS_47cc.html" title="ALAS">ALAS</a>), a rate-limiting enzyme involved in the production of <a href="../../../h/e/m/Heme.html" title="Heme">heme</a>. <a href="../../../m/a/l/Malate_dehydrogenase.html" title="Malate dehydrogenase">Malate dehydrogenase</a> and <a href="../../../s/u/c/Succinate_dehydrogenase.html" title="Succinate dehydrogenase">succinate dehydrogenase</a> also increase, as well as citrate synthase activity, in rats treated with AICAR injections (46). Conversely, in LKB1 knockout mice, there are decreases in cytochrome c and citrate synthase activity, even if the mice are “trained” by voluntary exercise (47).</p>
<p>Peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) is a transcriptional regulator for genes involved in mitochondrial biogenesis, <a href="../../../f/a/t/Fatty_acid_oxidation.html" title="Fatty acid oxidation">fatty acid oxidation</a>, and <a href="../../../g/l/u/Gluconeogenesis.html" title="Gluconeogenesis">gluconeogenesis</a> (48). To do this, it enhances the activity of <a href="../../../t/r/a/Transcription_factors.html" title="Transcription factors">transcription factors</a> like nuclear respiratory factor 1 (NRF-1), <a href="../../../m/y/o/Myocyte.html" title="Myocyte">myocyte</a> enhancer factor 2 (MEF2), host cell factor (HCF), and others (49, 50). It also has a <a href="../../../p/o/s/Positive_feedback_loop.html" title="Positive feedback loop">positive feedback loop</a>, enhancing its own expression (51). Both MEF2 and <a href="../../../c/a/m/CAMP_b3c2.html" title="CAMP">cAMP</a> response element (<a href="../../../c/r/e/CRE_6826.html" title="CRE">CRE</a>) are essential for contraction-induced PGC-1α <a href="../../../p/r/o/Promoter.html" title="Promoter">promoter</a> activity (50). AMPK is required for increased PGC-1α expression in skeletal muscle in response to <a href="../../../c/r/e/Creatine.html" title="Creatine">creatine</a> depletion (52). LKB1 knockout mice show a decrease in PGC-1α, as well as mitochondrial proteins (47).</p>
<p><br /></p>
<p><a name="Thyroid_Hormone_and_AMPK" id="Thyroid_Hormone_and_AMPK"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: Thyroid Hormone and AMPK">edit</a>]</span> <span class="mw-headline">Thyroid Hormone and AMPK</span></h2>
<p>AMPK and <a href="../../../t/h/y/Thyroid.html" title="Thyroid">thyroid</a> <a href="../../../h/o/r/Hormone.html" title="Hormone">hormone</a> regulate some similar processes. Knowing these similarities, Winder and Hardie et al designed an experiment to see if AMPK was influenced by <a href="../../../t/h/y/Thyroid_hormone.html" title="Thyroid hormone">thyroid hormone</a> (1). They found that all of the subunits of AMPK were increased in <a href="../../../s/k/e/Skeletal_muscle.html" title="Skeletal muscle">skeletal muscle</a>, especially in the <a href="../../../s/o/l/Soleus.html" title="Soleus">soleus</a> and red quadriceps, with thyroid hormone treatment. There was also an increase in phospho-ACC, a marker of AMPK activity.</p>
<p><br /></p>
<p><a name="Controversy" id="Controversy"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: Controversy">edit</a>]</span> <span class="mw-headline">Controversy</span></h2>
<p>A seemingly <a href="../../../p/a/r/Paradoxical.html" title="Paradoxical">paradoxical</a> role of AMPK occurs when we take a closer look at the energy-sensing <a href="../../../e/n/z/Enzyme.html" title="Enzyme">enzyme</a> in relation to exercise and long-term training. Similar to short-term acute training scale, long-term endurance training studies also reveal increases in oxidative metabolic enzymes and increases in GLUT-4, mitochondrial size and quantity, and an increased dependency on the oxidation of fatty acids; however, Winder et al. reported in <a href="../../../2/0/0/2002.html" title="2002">2002</a> that despite observing these increased oxidative biochemical adaptations to long-term endurance training (similar to those mentioned above), the AMPK response (activation of AMPK with the onset of exercise) to acute bouts of exercise decreased in <a href="../../../r/e/d/Red.html" title="Red">red</a> <a href="../../../q/u/a/Quadriceps.html" title="Quadriceps">quadriceps</a> (RQ) with training (3 – see Fig.1). Conversely, the study did not observe the same results in <a href="../../../w/h/i/White.html" title="White">white</a> <a href="../../../q/u/a/Quadriceps.html" title="Quadriceps">quadriceps</a> (WQ) and <a href="../../../s/o/l/Soleus.html" title="Soleus">soleus</a> (SOL) muscles that they did in RQ. The trained <a href="../../../r/a/t/Rat.html" title="Rat">rats</a> used for that endurance <a href="../../../s/t/u/Study.html" title="Study">study</a> ran on <a href="../../../t/r/e/Treadmill.html" title="Treadmill">treadmills</a> 5 days/wk in two 1-h sessions, <a href="../../../m/o/r/Morning.html" title="Morning">morning</a> and <a href="../../../a/f/t/Afternoon.html" title="Afternoon">afternoon</a>. The rats were also running up to 31m/min (grade 15%). Finally, following training, the rats were <a href="../../../s/a/c/Sacrifice.html" title="Sacrifice">sacrificed</a> either at rest or following 10 min. of exercise.</p>
<p>Because the AMPK response to exercise decreases with increased training duration, many questions arise that would challenge the AMPK role with respect to <a href="../../../b/i/o/Biochemical.html" title="Biochemical">biochemical</a> <a href="../../../a/d/a/Adaptation.html" title="Adaptation">adaptations</a> to exercise and endurance training. This is due in part to the marked increases in the <a href="../../../b/i/o/Biogenesis.html" title="Biogenesis">biogenesis</a> and upregulation of <a href="../../../m/i/t/Mitochondria.html" title="Mitochondria">mitochondria</a>, <a href="../../../g/l/u/GLUT-4_6fed.html" title="GLUT-4">GLUT-4</a>, UCP-3, <a href="../../../h/e/x/Hexokinase.html" title="Hexokinase">Hexokinase</a> II and other metabolic and mitochondrial enzymes despite decreases in AMPK activity with training. Questions also arise because <a href="../../../s/k/e/Skeletal_muscle.html" title="Skeletal muscle">skeletal muscle</a> <a href="../../../c/e/l/Cell_%28biology%29.html" title="Cell (biology)">cells</a> which express these decreases in AMPK activity in response to endurance training also seem to be maintaining an oxidative dependent approach to energy metabolism, which is likewise thought to be regulated to some extent by AMPK activity (38, 39).</p>
<p>If the AMPK response to exercise is responsible in part for biochemical adaptations to training, how then can these adaptations to training be maintained if the AMPK response to exercise is being attenuated with training? It is hypothesized that these <a href="../../../a/d/a/Adaptive.html" title="Adaptive">adaptive</a> roles to training are maintained by AMPK activity and that the increases in AMPK activity in response to exercise in trained skeletal muscle have not yet been observed due to biochemical adaptations that the training itself stimulated in the muscle tissue to reduce the metabolic need for AMPK activation. In other words, AMPK will not become activated until it is "apparent" that the cell is in need of greater <a href="../../../a/d/a/Adaptation.html" title="Adaptation">adaptation</a> to exercise. Until energy stores (ATP) are depleted (ATP low + AMP high), AMPK will remain inactivated. Biochemical preparations for a high-intensity energy challenge must be exhausted before AMPK is to be activated in order to mediate further metabolic adaptations to exercise.</p>
<p><br /></p>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<p>1.) Thomson DM, Porter BB, Tall JH, Kim HJ, Barrow JR, Winder WW. <i>Skeletal Muscle and Heart LKB1 Deficiency Causes Decreased Voluntary Running and Reduced Muscle Mitochondrial Marker Enzyme Expression in Mice.</i> Am J Physiol Endocrinol Meta. [Epub ahead of print], 2006.</p>
<p>2.) Ojuka EO. <i>Role of calcium and AMP kinase in the regulation of mitochondrial biogenesis and GLUT4 levels in muscle.</i> Proc Nutr Soc. 63: 275-278, 2004.</p>
<p>3.) Durante PE, Mustard KJ, Park SH, Winder WW, Hardie DG. <i>Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles.</i> Am J Physiol Endocrinol Metab. 283: 178-186, 2002.</p>
<p>4.) Winder WW, Hardie DG. <i>AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes.</i> Am J Physiol. 277: 1-10, 1999.</p>
<p>5.) Bergeron, R., R. R. Russell III, L. H. Young, J.-M. Ren, M. Marcucci, A. Lee, and G. I. Shulman. <i>Effect of AMPK activation on muscle glucose metabolism in conscious rats.</i> Am J Physiol. 276: 934-938, 1999.</p>
<p>6.) Rasmussen BB, Winder WW. <i>Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase.</i> J Appl Physiol 83: 1104-1109, 1997.</p>
<p>7.) Hutber CA, Rasmussen BB, Winder WW. <i>Endurance training attenuates the decrease in skeletal muscle malonyl-CoA with exercise.</i> J Appl Physiol 83: 1917-1922, 1997.</p>
<p>8.) Wojtaszewski JF, Nielsen P, Hansen BF, Richter EA, Kiens B. <i>Isoform-specific and exercise intensity-dependent activation of 5'-AMP-activated protein kinase in human skeletal muscle.</i> J Physiol 528: 221-226, 2000.</p>
<p>9.) Fujii N, Hayashi T, Hirshman MF, Smith JT, Habinowski SA, Kaijser L, Mu J, Ljungqvist O, Birnbaum MJ, Witters LA, Thorell A, Goodyear LJ. <i>Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle.</i> Biochem Biophys Res Commun 273: 1150-1155, 2000.</p>
<p>10.) Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. <i>Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.</i> Nat Med. 8: 1288-1295, 2002.</p>
<p>11.) Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T, House CM, Fernandez CS, Cox T, Witters LA, Kemp BE. <i>Mammalian AMP-activated protein kinase subfamily.</i> J Biol Chem 271: 611-614, 1996.</p>
<p>12.) Thornton C, Snowden MA, and Carling D. <i>Identification of a novel AMPK-activated protein kinase β subunit isoform that is highly expressed in skeletal muscle.</i> J Biol Chem 273: 12443-12450, 1998.</p>
<p>13.) Cheung PC, Salt IP, Davies SP, Hardie DG, Carling D. <i>Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding.</i> Biochem J 346: 659-69, 2000.</p>
<p>14.) Corton, J. M., J. G. Gillespie, S. A. Hawley, and D. G. Hardie. <i>5-Aminoimidazole-4-carboxamide ribonucleoside: a specific method for activating protein kinase in intact cells?</i> Eur J Biochem. 229: 558-565, 1995.</p>
<p>15.) Henin, N., M. F. Vincent, H. E. Gruber, and G. Van den Berghe. <i>Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase.</i> FASEB J. 9: 541-546, 1995.</p>
<p>16.) Henin, N., M. F. Vincent, and G. Van den Berghe. <i>Stimulation of rat liver AMP-activated protein kinase by AMP analogues.</i> Biochim Biophys Acta. 1290: 197-203, 1996.</p>
<p>17.) Sullivan, J. E., K. J. Brocklehurst, A. E. Marley, F. Carey, D. Carling, and R. K Beri. <i>Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase.</i> FEBS Lett. 353: 33-36, 1994.</p>
<p>18.) Hurst D, Taylor EB, Cline TD, Greenwood LJ, Compton CL, Lamb JD, Winder WW. AMP<i>-activated protein kinase kinase activity and phosphorylation of AMP-activated protein kinase in contracting muscle of sedentary and endurance-trained rats.</i> Am J Physiol Endocrinol Metab. 289: E710-E715, 2005.</p>
<p>19.) Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, and Hardie DG. Characterization <i>of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase.</i> J Biol Chem 271: 27887–27879, 1996.</p>
<p>20.) Stein SC, Woods A, Jones NA, Davison MD, and Carling D. <i>The regulation of AMP-activated protein kinase by phosphorylation.</i> Biochem J 345: 437–443, 2000.</p>
<p>21.) Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, Alessi DR, and Hardie DG. <i>Complexes between the LKB1 tumor suppressor, STRADalpha/beta and MO25alpha/beta are upstream kinases in the AMP-activated protein kinase cascade (Abstract).</i> J Biol Chem 2: 28, 2003.</p>
<p>22.) Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M, and Carling D. <i>LKB1 is the upstream kinase in the AMP-activated protein kinase cascade.</i> Curr Biol 13: 2004–2008, 2003.</p>
<p>23.) Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA,and Cantley LC. <i>The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress.</i> Proc Natl Acad Sci USA 101: 3329–3335, 2004.</p>
<p>24.) Davies SP, Helps NR, Cohen PT, and Hardie DG. <i>5'-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C alpha and native bovine protein phosphatase-2AC.</i> FEBS Lett 377: 421–425, 1995.</p>
<p>25.) Winder WW, Hardie DG. <i>Inactivation of acetyl-CoA carboxylase and activation of AMP-activated protein kinase in muscle during exercise.</i> Am J Physiol 270: E299-304, 1996.</p>
<p>26.) Carling D, Hardie DG. <i>The substrate and sequence specificity of the AMP-activated protein kinase. Phosphorylation of glycogen synthase and phosphorylase kinase.</i> Biochim Biophys Acta 1012: 81-86, 1989.</p>
<p>27.) Corton JM, Gillespie JG, Hardie DG. <i>Role of the AMP-activated protein kinase in the cellular stress response.</i> Curr Biol 4: 315-324, 1994.</p>
<p>28.) Hayashi T, Hirshman MF, Kurth EJ, Winder WW, Goodyear LJ. <i>Evidence for 5’ AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport.</i> Diabetes 47(8): 1369-1373, 1998.</p>
<p>29.) Hutber CA, Hardie DG, Winder WW. <i>Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase.</i> Am J Physiol. 272: E262-E266, 1997.</p>
<p>30.) Ouchi N, Shibata R, Walsh K. <i>AMP-activated protein kinase signaling stimulates VEGF expression and angiogenesis in skeletal muscle</i>. Circ Res. 96: 838-846, 2005.</p>
<p>31.) Bergeron R, Ren JM, Cadman KS, Moore IK, Perret P, Pypaert M, Young LH, Semenkovich CF, Shulman GI. <i>Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis.</i> Am J Physiol Endocrinol Metab. 281: E1340-E1346, 2001.</p>
<p>32.) Zong H, Ren JM, Young LH, Pypaert M, Mu J, Birnbaum MJ, Shulman GI. <i>AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation.</i> Proc Natl Acad Sci USA. 99: 15983- 15987, 2002.</p>
<p>33.) Ojuka EO, Jones TE, Nolte LA, Chen M, Wamhoff BR, Sturek M, Holloszy JO. <i>Regulation of GLUT4 biogenesis in muscle: evidence for involvement of AMPK and Ca(2+).</i> Am J Physiol Endocrinol Metab. 282: E1008-E1013,2002.</p>
<p>34.) Winder WW, Holmes BG, Rubink DS, Jensen EB, Chen M, Holloszy JO. <i>Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle.</i> J Appl Physiol. 88: 2216-2219, 2000.</p>
<p>35.) Stoppani J, Hildebrandt AL, Sakamoto K, Cameron-Smith D, Goodyear LJ, Neufer PD. <i>AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle.</i> Am J Physiol Endocrinol Metab. 283: E1239-E1248, 2002.</p>
<p>36.) Winder WW. <i>Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle.</i> J Appl Physiol. 91: 1017-1028, 2001.</p>
<p>37.) Holmes BF, Kurth-Kraczek EJ, Winder WW. <i>Chronic activation of 5’-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle.</i> J Appl Physiol. 87: 1990-1995, 1999.</p>
<p>38.) Lee WJ, Kim M, Park HS, Kim HS, Jeon MJ, Oh KS, Koh EH, Won JC, Kim MS, Oh GT, Yoon M, Lee KU, Park JY. <i>AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.</i> Biochem Biophys Res Commun. 340: 291-295, 2006.</p>
<p>39.) Suwa M, Egashira T, Nakano H, Sasaki H, Kumagai S. <i>Metformin increases the PGC-1{alpha} protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo.</i> J Appl Physiol. [Epub ahead of print], 2006.</p>
<p>40.) Hayashi, T, Hirshman MF, Fujii N, Habinowski SA, Witters LA, and Goodyear LJ. <i>Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism.</i> Diabetes. 49: 527-531, 2000.</p>
<p>41.) Kurth-Kraczek, EJ, Hirshman MF, Goodyear LJ, and Winder WW. <i>5’ AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle.</i> Diabetes. 48: 1667-1671, 1999.</p>
<p>42.) Merrill, GF, Kurth EJ, Hardie DG, and Winder WW. <i>AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle.</i> Am J Physiol Endocrinol Metab. 273: E1107-E1112, 1997.</p>
<p>43.) Ojuka EO, Nolte LA, Holloszy JO. <i>Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro.</i> J Appl Physiol. 88:1072-1075, 2000.</p>
<p>44.) Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB. <i>Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase.</i> Nature. 415: 268-269, 2002.</p>
<p>45.) Taylor EB, Hurst D, Greenwood LJ, Lamb JD, Cline TD, Sudweeks SN,Winder WW. <i>Endurance training increases LKB1 and MO25 protein but not AMP-activated protein kinase kinase activity in skeletal muscle.</i> Am J Physiol Endocrinol Metab. 287: E1082-9, 2004.</p>
<p>46.) Taylor EB, Lamb JD, Hurst RW, Chesser DG, Ellingson WJ, Greenwood LJ, Porter BB, Herway ST, Winder WW. <i>Endurance Training Increases Skeletal Muscle LKB1 and PGC-1alpha Protein Abundance: Effects of Time and Intensity.</i> Am J Physiol Endocrinol Metab. 289: E960-968, 2005.</p>
<p>47.) Sakamoto K, Goransson O, Hardie DG, Alessi DR. <i>Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.</i> Am J Physiol Endocrinol Metab. 287: E310-317, 2004.</p>
<p>48.) Taylor EB, Ellingson WJ, Lamb JD, Chesser DG, and Winder WW. <i>Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25.</i> Am J Physiol Endocrinol Metab. 288: E1055–E1061, 2005.</p>
<p>49.) Adams J, Chen ZP, Van Denderen BJ, Morton CJ, Parker MW, Witters LA, Stapleton D, Kemp BE. <i>Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site.</i> Protein Sci. 13(1): 155-165, 2004.</p>
<p>50.) Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF, Van den Berghe G, Carling D, Hue L. <i>Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischemia.</i> Curr Biol. 10(20): 1247-1255, 2000.</p>
<p>51.)Hardie, GH, Hawley, SA. <i>AMP-Activated Protein Kinase: The Energy Charge Hypothesis Revisited.</i> Bioessays. 2001. 23 (12) 1112-1119. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11746230" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11746230">PMID 11746230</a>.</p>
<p>52.) Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB. <i>AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.</i> <a href="../../../n/a/t/Nature_%28journal%29.html" title="Nature (journal)">Nature</a> 2004;428:569-74. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15058305" class="external" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15058305">PMID 15058305</a>.</p>
<p>53.) Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. <i>Role of AMP-activated protein kinase in mechanism of metformin action.</i> J Clin Invest 2001;108:1167–1174. DOI <a href="http://dx.doi.org/10.1172/JCI200113505" class="external text" title="http://dx.doi.org/10.1172/JCI200113505" rel="nofollow">10.1172/JCI200113505</a>.</p>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="../../../m/e/d/Medical_Subject_Headings_c75c.html" title="Medical Subject Headings">MeSH</a> <i><a href="http://www.nlm.nih.gov/cgi/mesh/2007/MB_cgi?mode=&amp;term=AMP-activated+protein+kinase" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2007/MB_cgi?mode=&amp;term=AMP-activated+protein+kinase" rel="nofollow">AMP-activated+protein+kinase</a></i></li>
</ul>
<p><br /></p>
<div class="NavFrame" style="clear:both;">
<div class="NavHead" style="background:#e7dcc3;">
<div class="noprint plainlinksneverexpand" style="background-color:transparent; padding:0; font-weight:normal; font-size:xx-small; color:#000000; white-space:nowrap; position:absolute; width:auto; left:0.5em;"><a href="../../../s/e/r/Template%7ESerine_threonine-specific_protein_kinases_44cd.html" title="Template:Serine/threonine-specific protein kinases"><span title="View this template">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<span style="color: #002bb8;" title="Discussion about this template">d</span>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org../../../s/e/r/Template%7ESerine_threonine-specific_protein_kinases_44cd.html" class="external text" title="http://en.wikipedia.org../../../s/e/r/Template%7ESerine_threonine-specific_protein_kinases_44cd.html" rel="nofollow"><span style="color: #002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
<b><a href="../../../k/i/n/Kinase.html" title="Kinase">Kinases</a>: <a href="../../../s/e/r/Serine_threonine-specific_protein_kinase_6282.html" title="Serine/threonine-specific protein kinase">Serine/threonine-specific protein kinases</a> (<a href="../../../e/c/_/EC_number_9459.html" title="EC number">EC</a> 2.7)</b></div>
<div class="NavContent" style="margin:0.5em; font-size:0.9em;">
<p><strong class="selflink">AMP-activated</strong> - <a href="../../../a/u/r/Aurora_kinase.html" title="Aurora kinase">Aurora</a> (<a href="../../../a/u/r/Aurora_A_kinase_5134.html" title="Aurora A kinase">A</a>, <a href="../../../a/u/r/Aurora_B_kinase_83bc.html" title="Aurora B kinase">B</a>) - <a href="../../../b/e/t/Beta_adrenergic_receptor_kinase.html" title="Beta adrenergic receptor kinase">Beta adrenergic receptor</a> - <a href="../../../b/o/n/Bone_morphogenetic_protein_receptors.html" title="Bone morphogenetic protein receptors">Bone morphogenetic protein receptors</a> - <a href="../../../c/-/r/C-Raf_1e25.html" title="C-Raf">c-Raf</a> - <a href="../../../c/a/2/Ca2%2B_calmodulin-dependent_protein_kinase_e05d.html" title="Ca2+/calmodulin-dependent protein kinase">Ca2+/calmodulin-dependent</a> (<a href="../../../m/y/o/Myosin_light-chain_kinase.html" title="Myosin light-chain kinase">Myosin light-chain</a>) - <a href="../../../c/d/k/CDKL5_29c1.html" title="CDKL5">CDKL5</a> - <a href="../../../c/y/c/Cyclin-dependent_kinase.html" title="Cyclin-dependent kinase">Cyclin-dependent</a> - <a href="../../../e/i/f/EIF-2_kinase_add9.html" title="EIF-2 kinase">EIF-2</a> - <a href="../../../g/s/k/GSK-3_7fd7.html" title="GSK-3">GSK-3</a> - <a href="../../../m/a/m/Mammalian_target_of_rapamycin.html" title="Mammalian target of rapamycin">Mammalian target of rapamycin</a> - <a href="../../../m/i/t/Mitogen-activated_protein_kinase.html" title="Mitogen-activated protein kinase">Mitogen-activated</a>/<a href="../../../m/i/t/Mitogen-activated_protein_kinase_kinase.html" title="Mitogen-activated protein kinase kinase">MAP2K</a>/<a href="../../../m/a/p/MAP_kinase_kinase_kinase_55fa.html" title="MAP kinase kinase kinase">MAP3K</a> (<a href="../../../e/x/t/Extracellular_signal-regulated_kinases.html" title="Extracellular signal-regulated kinases">Extracellular signal-regulated</a>, <a href="../../../c/-/j/C-Jun_N-terminal_kinases_8227.html" title="C-Jun N-terminal kinases">C-Jun N-terminal</a>, <a href="../../../p/3/8/P38_mitogen-activated_protein_kinases.html" title="P38 mitogen-activated protein kinases">P38 mitogen-activated protein</a>) - <a href="../../../p/h/o/Phosphorylase_kinase.html" title="Phosphorylase kinase">Phosphorylase</a> - <a href="../../../r/h/o/Rhodopsin_kinase.html" title="Rhodopsin kinase">Rhodopsin</a><br />
<a href="../../../c/a/m/CAMP-dependent_protein_kinase_8c35.html" title="CAMP-dependent protein kinase">Protein kinase A</a> - <a href="../../../a/k/t/AKT_7ed9.html" title="AKT">Protein kinase B</a> - <a href="../../../p/r/o/Protein_kinase_C_89b6.html" title="Protein kinase C">Protein kinase C</a> - <a href="../../../c/g/m/CGMP-dependent_protein_kinase_3be4.html" title="CGMP-dependent protein kinase">Protein kinase G</a></p>
</div>
</div>

<!-- 
Pre-expand include size: 6014 bytes
Post-expand include size: 6257 bytes
Template argument size: 1958 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/m/p/AMP-activated_protein_kinase_c0de.html">http://en.wikipedia.org../../../a/m/p/AMP-activated_protein_kinase_c0de.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Category</a>: <span dir='ltr'><a href="../../../p/r/o/Category%7EProtein_kinases_37ab.html" title="Category:Protein kinases">Protein kinases</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/m/p/AMP-activated_protein_kinase_c0de.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/m/p/Talk%7EAMP-activated_protein_kinase_53dc.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/AMP-activated_protein_kinase">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 19:55, 29 March 2007 by Wikipedia user <a href="../../../p/e/k/User%7EPekaje_a76b.html" title="User:Pekaje">Pekaje</a>. Based on work by Wikipedia user(s) <a href="../../../b/_/p/User%7EB_Pete_d002.html" title="User:B Pete">B Pete</a>, Giantgroundsloth, <a href="../../../g/r/e/User%7EGreenrd_ce6f.html" title="User:Greenrd">Greenrd</a>, <a href="../../../j/o/h/User%7EJohnCub_3730.html" title="User:JohnCub">JohnCub</a>, <a href="../../../y/k/_/User%7EYK_Times_f4c6.html" title="User:YK Times">YK Times</a>, <a href="../../../a/r/c/User%7EArcadian_5c4b.html" title="User:Arcadian">Arcadian</a>, <a href="../../../o/r/p/User%7EOrphanBot_88cf.html" title="User:OrphanBot">OrphanBot</a>, Johhhhny, <a href="../../../s/h/r/User%7EShrimp_wong_30b7.html" title="User:Shrimp wong">Shrimp wong</a>, Domaine63, Rmilleruw, <a href="../../../b/l/u/User%7EBluebot_e595.html" title="User:Bluebot">Bluebot</a>, <a href="../../../k/j/a/User%7EKjaergaard_efff.html" title="User:Kjaergaard">Kjaergaard</a>, <a href="../../../j/f/d/User%7EJfdwolff_9ea6.html" title="User:Jfdwolff">Jfdwolff</a>, <a href="../../../p/e/t/User%7EPetersam_7af3.html" title="User:Petersam">Petersam</a>, <a href="../../../b/r/y/User%7EBryan_Derksen_3ce8.html" title="User:Bryan Derksen">Bryan Derksen</a> and <a href="../../../s/e/g/User%7ESeglea_8627.html" title="User:Seglea">Seglea</a> and Anonymous user(s) of Wikipedia.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
